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ABSTRACT
Introduction Infectious diseases pose a risk to public
health, requiring efficient strategies for disease prevention.
Digital health surveillance technologies provide new
opportunities to enhance disease prevention, detection,
tracking, reporting and analysis. However, in addition to
concerns regarding the effectiveness of these technologies
in meeting public health goals, there are also concerns
regarding the ethics, legality, safety and sustainability
of digital surveillance technologies. This scoping review
examines the literature on digital surveillance for public
health purposes during the COVID-19 pandemic to
identify health-related applications of digital surveillance
technologies, and to highlight discussions of the
implications of these technologies.
Methods and analysis The scoping review will be guided
by the framework proposed by Arksey and O’Malley and
the guidelines outlined by Colquhoun et al and Levac et al.
We will search Medline (Ovid), PsycInfo, PubMed, Scopus,
CINAHL (EBSCOhost), ACM Digital Library, Google Scholar
and IEEE Explore for relevant studies published between
December 2019 and December 2020. The review will also
include grey literature. Data will be managed and analysed
through an extraction table and thematic analysis.
Ethics and dissemination Findings will be disseminated
through traditional academic channels, as well as social
media channels and research briefs and infographics.
We will target our dissemination to provincial and federal
public health organisations, as well as technology
companies and community-based organisations managing
the public response to the COVID-19 pandemic.

INTRODUCTION
The COVID-
19 pandemic constitutes an
unparalleled global crisis impacting all
matters that determine health (eg, environment, economy, health services) and
has been described as the first pandemic of
‘the algorithmic age’ where advanced data
analytics are contributing to sophisticated
detection, treatment and prevention strategies.1 Bennet et al2 describe surveillance
practices as central to all organisations and
sectors, and encourage attentiveness to

Strengths and limitations of this study
►► This scoping review will highlight existing evidence

of digital surveillance strategies for disease mitigation used during the COVID-19 pandemic and identify any gaps in the literature related to technology
type, design, and implementation of digital surveillance strategies, and implications related to data
ownership, privacy and the sustainability of these
initiatives.
►► Our focus on the global context will allow us to compare uses of digital health surveillance technology
across regions and nations.
►► Our search of the literature draws on a wide variety
of databases and employs a broad understanding of
digital health surveillance technology.
►► Our focus is on digital health surveillance technology used during the COVID-19 pandemic, which
may limit our ability to investigate forms of digital
surveillance used during previous pandemics, epidemics and outbreaks. While we initially intended to
review publications from 2000 to 2020 to trace the
use of digital health surveillance technologies over
time and during different outbreaks, our literature
search yielded an unmanageable number of results
that we could not review with our available time and
resources. As such, this review has been limited to
surveillance technologies used during the COVID-19
pandemic. While this limit in scope will exclude the
opportunity to analyse developments in the use of
digital health surveillance technology over time, our
team of researchers found that limiting the scope
to the COVID-19 pandemic was the most effective
means of retaining a manageable number of publications for review while also answering our modified
research questions.
►► Including only publications written in English will
exclude discussions and analyses of digital health
surveillance technology in other languages, which
may limit our capacity to take a global approach.

misuse of data collected for another purpose:
function or mission creep.2 Defined as ‘the
focused, systematic, and routine attention
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while data can save lives at times of global public
health crisis…it can only do this effectively if its use,
management and governance, even at times of crisis, is underpinned by clear rules (grounded in law,
ethics and human rights) about how best to use data;
and trust in institutions to use data well.
However, the urgency to control the spread of
COVID-19 has effectively limited opportunities to thoroughly consider the intended (disease containment) and
unintended (eg, violation of ethical practices and human
rights standards) consequences.17 Digital surveillance
technologies that bear on determinants of health require
regulatory oversight that accounts for transparency, diversity, networks of control, influence and the potential for
the exploitation of citizen data by public and private
organisations.18 19
2

This scoping review aims to investigate the peer-reviewed
and grey literature on the use of digital surveillance technologies for public health mitigation purposes during the
COVID-19 pandemic and within the global context. The
objectives of the scoping review are as follows:
►► To review the breadth and depth of the academic and
grey literature on digital health surveillance technologies and their use during the COVID-19 pandemic.
►► To explore how the literature has taken up and
addressed the short-term and long-term implications
of digital surveillance technology on diverse populations, particularly those who are marginalised or
facing existing inequities.
►► To identify gaps in the peer-
reviewed and grey
literature.
METHODS AND ANALYSIS
We will conduct a scoping review with guidance from
Arksey and O’Malley,20 Colquhoun et al,21 Levac et al,22
and the Joanna Briggs Institute guidelines.20–23 A scoping
review was determined to be the most appropriate means
of addressing our research objectives, as our intent is to
explore what is known about digital surveillance technologies for public health purposes and to investigate
the state of the literature. To this end, we look to use a
scoping strategy to map relevant literature in the field of
interest.20 Our aim is to convey the breadth and depth
of the peer-reviewed and grey literature on this topic.21
We will also trace these various forms of investigation and
discussions to identify any gaps that might exist.
This scoping review will follow the methodological
framework described by Arksey and O’Malley,20 which
comprises five stages: (1) identifying the research question, (2) identifying relevant studies, (3) study selection,
(4) charting the data, (5) collating, summarising and
reporting the results.20 In writing this scoping review
protocol, we also drew on the Preferred Reporting Items
for Systematic Review and Meta-Analysis (PRISMA) Protocols reporting guidelines.24
Stage 1: identifying the research question
Our scoping review will be guided by the following research
question: What is known about digital health surveillance
technologies targeted at citizen surveillance during the
COVID-19 pandemic within the global context? In addition to this research question, we also seek to answer the
following subquestions: (1) What are the health-related
applications of digital surveillance technology strategies?
(2) What are the existing and/or predicted short-term
and long-term implications of digital surveillance technology on diverse cultural, criminalised, Indigenous,
disabled and otherwise marginalised populations?
Stage 2: identifying relevant literature
Our interdisciplinary team of researchers informed the
adoption of an expansive definition of digital health
surveillance technologies that includes any use of technology with the goal of making someone, or something, visible
Donelle L, et al. BMJ Open 2021;11:e053962. doi:10.1136/bmjopen-2021-053962
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to personal details for purposes of influence, management, protection or direction’,3 surveillance constitutes
a long-standing practice within public health. There has
been a surge in digital surveillance technology development by academics, private sector companies and ‘citizen
scientists’ to support public health practices (eg, contact
tracing, physical distancing).1 4
The use of existing digital surveillance technologies has
also been leveraged and redirected to support pandemic
management.5 To date, the use of technology to mitigate
the spread of COVID-19 within and across countries has
achieved varying levels of success, dependent on indicators of success (eg, disease containment (testing, vaccinations), mortality, educational/school attendance,
employment rate, real gross domestic product), which
vary geographically. Globally, governments are considering, or are currently using, digital surveillance technologies (eg, cellphone geolocation, closed-circuit cameras,
apps) and mass public data collection (eg, wastewater
surveillance) to detect and mitigate the spread of the
COVID-19 virus, and to ensure compliance with public
health measures.6
There have also been concerns about (mis)uses of
digital technology measures during pandemic and
non-
pandemic situations. Many have voiced concerns
regarding the short-
term and long-
term potentials of
these technologies, including undermining human
rights,7 threatening our fundamental values,8 9 inequitable targeting of oppressed and racialised communities,10
biases embedded in coding leading to discriminatory
practices,11–13 inequitable power structures14 and engendering a false sense of security.15 Researchers, human
rights advocates and knowledge leaders in digital technology are insistent that governments and healthcare
decision-
makers balance technological innovation as
a pandemic response with transparency, diligence and
attentiveness to issues of data standards, ethics, equity
and human rights to effectively address the short-term
and long-
term implications on health and issues that
determine health.16 Patel,17 for instance, argues that:
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1. Population Surveillance/or Public Health Surveillance/or surveil2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

lance.tw.
digital surveillance.tw.
biosurveillance.tw. or Biosurveillance/
epidemiological monitoring.tw. or Epidemiological monitoring/
1 or 2 or 3 or 4
pandemic.tw. or Pandemics/
disease outbreak.tw. or Disease Outbreaks/
Coronavirus Infections/or covid-19.tw.
covid19.tw.
H1N1.tw.
SARS.tw. or SARS Virus/
6 or 7 or 8 or 9 or 10 or 11
Public Health/or public health application.mp.
5 and 12

for public health purposes. We developed our search
strategy through ongoing consultations with a specialist
subject librarian, who assisted in developing the search
strategy and identifying relevant databases. The search
strategy will include pertinent and comprehensive search
terms that represent the primary concepts of this scoping
review’s objectives. These consist of keywords and medical
subject headings (MeSH) terms, as well as combinations
of these terms using Boolean operators (box 1). The
search strategy and keywords will be adjusted for each
database (see online supplemental file 1).
An electronic search will be conducted using the
following databases: Medline (Ovid), PsycInfo (Ovid),
PubMed, Scopus, CINAHL, ACM Digital Library, Google
Scholar and IEEE Explore. The databases were chosen
with the intention of including perspectives from health,
public health, engineering, computer science, data ethics
and other specialist fields on the use of technology for
health surveillance purposes. We will also hand search
key journals and the reference lists of relevant articles for
additional publications that may have been missed from
the database searches. All references will be exported to
a reference manager software to organise references and
remove duplicates.
Grey literature from organisations with relevance
to the focus of our research (eg, digital health, surveillance, data/human rights, ethics, equity, privacy) will be
included. With the help of a research librarian, our team
of interdisciplinary researchers selected relevant organisational websites that explore the use and applications
of digital technology for surveillance purposes. We will
conduct a search of these websites to retrieve potentially
relevant grey literature. These sites include: the Canadian
Agencies for Drugs and Technology in Health, the Ada
Lovelace Institute, the Center for International Governance Innovation, the Geneva Internet Platform, Munk
Updates, Human Rights Watch, the International Civil
Liberties Monitoring Group, the Surveillance Studies
Centre at Queen’s University, the Information and Privacy
Donelle L, et al. BMJ Open 2021;11:e053962. doi:10.1136/bmjopen-2021-053962

Commissioner of Ontario, Privacy International, Amnesty
International, the International Association of Privacy
Professionals, PreventionWeb, the National Health Policy
Forum and the Mitre.
These websites will be searched through a manual
search of current and archived contents and, where applicable, through the use of the internal search tool on each
website. We will use similar key terms to those being used
to search the peer-reviewed literature. Any relevant literature published between December 2019 and December
2020 will be retained for further review. Links to potentially relevant publications will be extracted to a spreadsheet for further screening by two researchers.
Stage 3: literature selection
Inclusion criteria
We began with a broad search of the literature to capture
all publications on the use of digital health surveillance
technology during pandemics, epidemics and outbreaks
published between January 2000 and December 2020. As
we are interested in the global use of digital health surveillance technologies, we included publications written
from, and about, all countries and regions. However, due
to limitations in time and resources, we only included
publications written in English. This search yielded 9630
results. From these results, we screened the abstracts
based on the following inclusion criteria:
►► The publication must include mention of the use of a
digital technology for public health surveillance.
►► This public health surveillance must be oriented
towards the containment or mitigation of the spread
of an infectious disease.
►► Public health surveillance through digital technology
must be focused on surveilling humans, not non-
human animals.
After screening the abstracts, we retained 2076 publications for inclusion. Next, we read each publication
to screen against the inclusion criteria listed above.
Following this screening process, we retained 888 publications for review.
Given the resources and time available to us, it was
impractical to attempt a scoping review of over 800 publications. Our research team trialled several ways of further
limiting our scope as a means of reducing this number.
We experimented with limiting the scope by technology,
by region, by methodology and according to whether the
technology was publicly or privately funded, but these
exclusions either limited the scope in such a way that we
could not answer our research questions or were ineffective at reducing the number of included publications to a
manageable amount.
We next attempted to limit the scope to focusing solely
on digital health surveillance technologies used during
the COVID-19 pandemic. We refined our inclusion criteria
to limit the publication timeframe from December 2019
to December 2020, and we excluded publications that
did not have the terms ‘coronavirus’, ‘COVID19’, ‘SARS-
CoV-2’ or ‘severe acute respiratory syndrome coronavirus
3
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Box 1 Search strategy and search terms developed in
consultation with the research librarian
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Figure 1 Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) chart detailing the study
selection process.

2’ in the title or abstract. These inclusion criteria reduced
the number of retained publications to 172. After consultation with the research team, we agreed that this limited
scope reduced the number of publications for review to
a manageable amount, while also ensuring that we could
answer our research questions if we modified them to
focus solely on the COVID-19 pandemic.
Title and abstract screening was conducted by two
researchers. Included articles were imported into
Mendeley for full-article screening by five researchers.
Any discrepancies were discussed among the researchers
until a consensus was reached.
Stage 4: charting the data
After searching the databases, all identified citations were
uploaded to Mendeley 1.19.4/2019 (Elsevier) and duplicates removed. Titles and abstracts of all articles were
screened by two independent reviewers to determine if
they met the study’s inclusion criteria. Potentially relevant
articles were reviewed in full against the inclusion criteria
by two independent reviewers. Disagreements between
the two reviewers at any stage were resolved through
mutual discussion or, where necessary, consultation with
a third reviewer. The results and study inclusion process
will be presented on a PRISMA extension for Scoping
Reviews flow chart22 (figure 1).
We will use a targeted rule set to extract 12 relevant
pieces of data from the included articles. This data
extraction table will be developed in accordance with
the objectives of our scoping review, as well as domain-
specific expertise from members of our research team to
ensure that we identify all relevant information. The data
extracted from all relevant documents will include the
4

Stage 5: collating, summarising and reporting the results
In line with our objective of mapping the breadth and
depth of the literature, we will conduct a thematic analysis of the data extracted from the articles with the goal
of identifying what kinds of studies of digital health
surveillance technologies have been conducted; which
technologies, countries and surveillance implications
have been studied; what debates, discussions and tensions
have emerged within the literature; and, where applicable, what gaps exist in the literature. The analysis will
be undertaken as a collective effort among our team of
researchers to ensure an interdisciplinary analysis from
multiple expert perspectives.
PATIENT AND PUBLIC INVOLVEMENT
Patients and the public were not involved in this research
in any way.
DISCUSSION
The aim of this scoping review is to explore the literature
on digital health surveillance technology, with the goal
of mapping the research that has been done in this area,
understanding the implications of use and highlighting
any gaps. As digital health surveillance technologies are
leveraged by countries around the world in an attempt
to manage the COVID-19 pandemic, there is an urgent
need to understand the potential short-term and long-
term implications of technology use. We anticipate that
the results of this scoping review will support informed
decision-
making around digital surveillance use and
provide important insight into the existing knowledge
of digital health surveillance technologies and the use of
these forms of surveillance in monitoring and mitigating
pandemics.
ETHICS AND DISSEMINATION
Given we are reviewing secondary sources and not
working with human subjects, our scoping review
did not require ethics approval. The findings of our
scoping review will be disseminated through traditional academic channels, including peer-
reviewed
publications and conference presentations. We will
also engage targeted public organisations through
social media channels and accessible research briefs
Donelle L, et al. BMJ Open 2021;11:e053962. doi:10.1136/bmjopen-2021-053962
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following: (1) author(s), (2) year of publication, (3) type
of document, (4) aim or study purpose, (5) methodology,
(6) countries or regions studied, (7) type(s) of digital
surveillance technology studied, (8) how the technology
under study is used for disease surveillance, (9) target
population(s), (10) key findings, (11) outcomes, and
(12) implications of technology use (eg, ethical, political,
etc). Five researchers will pilot the data extraction table
on five articles and then discuss the findings to determine
whether adjustments need to be made.
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and infographics, developed with our interdisciplinary
team of researchers. We will target our dissemination to
global public health organisations. We will also target
technology industry companies and community-based
organisations dealing with the public response to the
COVID-19 pandemic. Dissemination of our findings is
intended to generate a shared understanding of the
concept of digital surveillance, and to facilitate reflection and discussion on the benefits and challenges of
pandemic surveillance strategies.

